US Patent Issued to Pfizer on Aug. 25 for "5-(thiophen-2-yl)-1 H-tetrazole derivative as BCKDK inhibitors useful for treating various diseases" (Massachusetts, Connecticut Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,863, issued on Aug. 25, was assigned to Pfizer Inc. (New York).

"5-(thiophen-2-yl)-1 H-tetrazole derivative as BCKDK inhibitors useful for treating various diseases" was invented by Samit Kumar Bhattacharya (Waltham, Mass.), Christopher Ryan Butler (Canton, Mass.), Kevin James Filipski (Reading, Mass.), Bethany Lyn Kormos (Somerville, Mass.), Luis Angel Martinez-Alsina (Gales Ferry, Conn.), Russell Alan Miller (Dedham, Mass.), Kiyoyuki Omoto (Bedford, Mass.), Brian Raymer (Holliston, Mass.), Matthew Richard Reese (Mystic, Conn.), Rachel Jane Roth Flach (Rockland, Mass.) and Yuan Zhang (Mansfield, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "...